NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Cancer Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Cancer Vaccines



Scientists at Veterans Affairs Medical Center publish research in cancer vaccines



February 27th, 2007

Scientists discuss in "Antigenic profiling of glioma cells to generate allogeneic vaccines or dendritic cell-based therapeutics" new findings in cancer. "Allogeneic glioma cell lines that are partially matched to the patient at class I human leukocyte antigen (HLA) loci and that display tumor-associated antigens (TAA) or antigenic precursors [tumor antigen precursor proteins (TAPP)] could be used for generating whole tumor cell vaccines or, alternatively, for extraction of TAA peptides to make autologous dendritic cell vaccines. Twenty human glioma cell lines were characterized by molecular phenotyping and by flow cytometry for HLA class I antigen expression," scientists writing in the...


Source: Cancer Weekly (2007-02-27)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login